12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 09 Oct 2025 20:31:40 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Fri, 10 Oct 2025 20:31:40 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=%2BhsAe%2BnpjN%2B6Y7BjyoqMC8Vbx7rq604qjR%2FDHoFL93MAMJGz83jbj9bG5l9aiJq9J%2B2PjLmDaLMYVfNP5%2B0FMFry%2FPj9fXJzJO0Sfdo%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=80 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6Ik5mOUFRS0pSc21kZU4xaXo0TXUxOWc9PSIsInZhbHVlIjoiYTd3XC9zRU5Sa2JUTG1aOGR2aGY0enIwcVlmcUs0Z05hOElPS3RVanR3Q0ZSaUVwdG1iNm9PM0ZuVFJVcjIrWDRyb0RZcWI5THh6c2VTNEoyNWlFb2RnPT0iLCJtYWMiOiI4NDI3NmRmYTY5ZWFhYjBlNTY4MDZiNDA4ZDkzMTg4ZGNmZGU1YTJjZGE1YzJiNGI5YmExZWIzMDc4OWQzNzU2In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 08 Oct 2028 20:31:40 GMT [24] => CF-RAY: 98c0a4949ff79a6e-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

世界卫生组织会议的联席主持人周三表示，中国科学家正在测试两种针对2019年新型冠状病毒（COVID-19）的抗病毒药物，初步临床试验结果将在几周后公布。

根据路透社报道，前世卫组织病毒学家玛丽保罗基尼（Marie-Paule Kieny）博士与其他人共同主持了在日内瓦举行的为期2天的闭门研究论坛，有300多名科学家和研究人员参加，其中一些中国内地和台湾的科学家通过视讯参与了会议。

她周三在新闻发布会上透露，很多病人已经服用了抗病毒药物利托那韦（ritonavir）和洛匹那韦（lopinavir）联合干扰素，但是她没有确切的数据。